BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32650408)

  • 1. Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Carretero-Barrio I; Palacios-Berraquero ML; Perez-García J; Cortés J; Palacios J
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
    Krings G; Chen YY
    Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected].
    Weigelt B; Ng CK; Shen R; Popova T; Schizas M; Natrajan R; Mariani O; Stern MH; Norton L; Vincent-Salomon A; Reis-Filho JS
    Mod Pathol; 2015 Mar; 28(3):340-51. PubMed ID: 25412848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
    González-Martínez S; Pérez-Mies B; Pizarro D; Caniego-Casas T; Cortés J; Palacios J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
    McCart Reed AE; Kalaw E; Nones K; Bettington M; Lim M; Bennett J; Johnstone K; Kutasovic JR; Saunus JM; Kazakoff S; Xu Q; Wood S; Holmes O; Leonard C; Reid LE; Black D; Niland C; Ferguson K; Gresshoff I; Raghavendra A; Harvey K; Cooper C; Liu C; Kalinowski L; Reid AS; Davidson M; Pearson JV; Pathmanathan N; Tse G; Papadimos D; Pathmanathan R; Harris G; Yamaguchi R; Tan PH; Fox SB; O'Toole SA; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2019 Feb; 247(2):214-227. PubMed ID: 30350370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.
    Piscuoglio S; Ng CKY; Geyer FC; Burke KA; Cowell CF; Martelotto LG; Natrajan R; Popova T; Maher CA; Lim RS; Bruijn I; Mariani O; Norton L; Vincent-Salomon A; Weigelt B; Reis-Filho JS
    NPJ Breast Cancer; 2017; 3():48. PubMed ID: 29214215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
    Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
    Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.
    Tadros AB; Sevilimedu V; Giri DD; Zabor EC; Morrow M; Plitas G
    Ann Surg Oncol; 2021 Aug; 28(8):4245-4253. PubMed ID: 33389291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
    Cossu-Rocca P; Orrù S; Muroni MR; Sanges F; Sotgiu G; Ena S; Pira G; Murgia L; Manca A; Uras MG; Sarobba MG; Urru S; De Miglio MR
    PLoS One; 2015; 10(11):e0141763. PubMed ID: 26540293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality imaging and histopathology of metaplastic breast cancer.
    Çelik H; Başara Akın I; Durak MG; Balcı P
    Diagn Interv Radiol; 2023 Jan; 29(1):59-67. PubMed ID: 36959869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1.
    Joneja U; Vranic S; Swensen J; Feldman R; Chen W; Kimbrough J; Xiao N; Reddy S; Palazzo J; Gatalica Z
    J Clin Pathol; 2017 Mar; 70(3):255-259. PubMed ID: 27531819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.
    Zhai J; Giannini G; Ewalt MD; Zhang EY; Invernizzi M; Niland J; Lai LL
    Hum Pathol; 2019 Apr; 86():85-92. PubMed ID: 30537493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer.
    Jouali F; Marchoudi N; Talbi S; Bilal B; El Khasmi M; Rhaissi H; Fekkak J
    BMC Cancer; 2018 Sep; 18(1):900. PubMed ID: 30227836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation.
    Beca F; Sebastiao APM; Pareja F; Dessources K; Lozada JR; Geyer F; Selenica P; Zeizafoun N; Wen HY; Norton L; Brogi E; Weigelt B; Reis-Filho JS
    Histopathology; 2020 Aug; 77(2):321-326. PubMed ID: 32043609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.
    Guerini-Rocco E; Piscuoglio S; Ng CK; Geyer FC; De Filippo MR; Eberle CA; Akram M; Fusco N; Ichihara S; Sakr RA; Yatabe Y; Vincent-Salomon A; Rakha EA; Ellis IO; Wen YH; Weigelt B; Schnitt SJ; Reis-Filho JS
    J Pathol; 2016 Apr; 238(5):677-88. PubMed ID: 26806567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intratumor heterogeneity, angiogenesis and epithelial to mesenchymal transition pathways in metaplastic breast cancer.
    Chouliaras K; Oshi M; Asaoka M; Tokumaru Y; Khoury T; Endo I; Ishikawa T; Takabe K
    Am J Cancer Res; 2021; 11(9):4408-4420. PubMed ID: 34659895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaplastic Breast Cancer: Current Understanding and Future Directions.
    Thomas A; Douglas E; Reis-Filho JS; Gurcan MN; Wen HY
    Clin Breast Cancer; 2023 Dec; 23(8):775-783. PubMed ID: 37179225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.